Vincent Peter Schultz

Title: Vincent Peter Schultz: Innovator in CDK2 Interactions

Introduction

Vincent Peter Schultz is a notable inventor based in Madison, CT (US). He has made significant contributions to the field of biochemistry, particularly in the study of protein interactions. His work focuses on the CDK2 protein, which plays a crucial role in cell cycle regulation.

Latest Patents

Vincent holds a patent related to CDK2 interactions. The patent describes complexes of the CDK2 protein with various proteins identified through a modified yeast two-hybrid assay system. The proteins that interact with CDK2 include cyclin H, cyclin I, ERH, and two splice variants of the gene hsReq, known as hsReq*-1 and hsReq*-2. This invention provides valuable insights into the complexes formed by CDK2 and these proteins, along with their derivatives, fragments, and analogs. Additionally, the patent includes nucleic acids encoding hsReq*-1 and hsReq*-2, as well as methods for screening these complexes for efficacy in treating diseases such as cancer, atherosclerosis, and neurodegenerative disorders.

Career Highlights

Vincent is associated with Curagen Corporation, where he applies his expertise in biochemistry and molecular biology. His innovative work has the potential to impact therapeutic strategies for various diseases.

Collaborations

Vincent has collaborated with notable colleagues, including Meijia Yang and Krishnan Nandabalan. These collaborations have likely contributed to the advancement of research in the field of protein interactions.

Conclusion

Vincent Peter Schultz is a distinguished inventor whose work on CDK2 interactions has the potential to lead to significant advancements in medical treatments. His contributions to the field of biochemistry are noteworthy and reflect his commitment to innovation.